US Patent Issued to Medtronic on Feb. 3 for "Therapy programming based on evoked compound action potentials" (Minnesota, Wisconsin, California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,425, issued on Feb. 3, was assigned to Medtronic Inc. (Minneapolis).

"Therapy programming based on evoked compound action potentials" was invented by Andrew L. Schmeling (Holmen, Wis.), Rebecca A. Miron (Center City, Minn.), Christopher J. Edwards (Mahtomedi, Minn.), David W. Simons (Edina, Minn.), Nikita Tandon (San Jose, Calif.) and Reid K. Bornhoft (Lina Lakes, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure is directed to devices, systems, and techniques for controlling electrical stimulation. In some examples, a computing device includes a therapy-management application configured to assist a user to: capture a representativ...